• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最大吸气流量和吸入量对易纳器干粉吸入器中福莫特罗药物沉积的影响。

Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler.

机构信息

Department of Pharmacy and Pharmaceutical Sciences, University of Huddersfield, Huddersfield HD1 3DH, United Kingdom.

Inhalation Consultancy Ltd, Yeadon, Leeds, LS19 7SP, United Kingdom.

出版信息

Eur J Pharm Sci. 2017 Jun 15;104:180-187. doi: 10.1016/j.ejps.2017.03.035. Epub 2017 Mar 27.

DOI:10.1016/j.ejps.2017.03.035
PMID:28351669
Abstract

Most patients using dry powder inhalers (DPIs) do not achieve the inhalation parameters recommended for pharmacopoeial in-vitro dose emission testing. The dose emission characteristics of formoterol from an Easyhaler® have been measured using the Andersen Cascade Impactor (ACI) with a maximum inhalation flow (MIF) of 28.3, 60 and 90L/min and inhaled volumes (Vin) of 240, 750, 1500 and 2000mL. The total emitted dose (TED) was significantly higher at 90L/min (p<0.05), but the difference in the TED between low (28.3L/min) and high (90L/min) flow rate was significantly reduced by increasing the Vin. The fine particle dose (FPD) was higher (p<0.05) at 90L/min for all Vin values compared to 28.3 and 60L/min. Similarly the mass median aerodynamic diameter (MMAD) was smaller at 90L/min across all Vin values. Dose emission characteristics were lower at 240mL for both MIFs. The results for 240mL could be due to an insufficient Vin pulled through the ACI or incomplete emptying of the dose metering cup. This study shows that the FPD, %FPF and MMAD were not significantly affected by the vin≥750mL and that an inhaled volume as low as 750mL could be used with the ACI.

摘要

大多数使用干粉吸入器(DPIs)的患者无法达到药典规定的体外剂量释放测试吸入参数。本文使用 Andersen Cascade Impactor(ACI)测量了福莫特罗从 Easyhaler®中的剂量释放特性,最大吸入流量(MIF)分别为 28.3、60 和 90L/min,吸入体积(Vin)分别为 240、750、1500 和 2000mL。在 90L/min 时总发射剂量(TED)显著更高(p<0.05),但通过增加 Vin,低(28.3L/min)和高(90L/min)流速之间 TED 的差异显著减小。与 28.3 和 60L/min 相比,所有 Vin 值下 90L/min 时的细颗粒剂量(FPD)更高(p<0.05)。同样,所有 Vin 值下 90L/min 时的质量中值空气动力学直径(MMAD)更小。对于两种 MIF,240mL 的剂量释放特性较低。240mL 的结果可能是由于 ACI 中通过的 Vin 不足或剂量计量杯未完全排空。这项研究表明,当 Vin≥750mL 时,FPD、%FPF 和 MMAD 不受影响,并且可以使用低至 750mL 的吸入体积与 ACI 配合使用。

相似文献

1
Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler.最大吸气流量和吸入量对易纳器干粉吸入器中福莫特罗药物沉积的影响。
Eur J Pharm Sci. 2017 Jun 15;104:180-187. doi: 10.1016/j.ejps.2017.03.035. Epub 2017 Mar 27.
2
Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler.利用慢性阻塞性肺疾病(COPD)患者的吸气特征研究基于胶囊的干粉吸入器中茚达特罗的药物输送均匀性和空气动力学剂量释放。
Eur J Pharm Sci. 2019 Jun 15;134:138-144. doi: 10.1016/j.ejps.2019.04.018. Epub 2019 Apr 18.
3
Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.流速对NEXThaler(®)与Diskus(®)和Turbohaler(®)干粉吸入器体外空气动力学性能的影响比较
J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):167-78. doi: 10.1089/jamp.2015.1220. Epub 2015 Sep 10.
4
Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.使用慢性阻塞性肺疾病患者的吸入谱,从 Spiromax®干粉吸入器中的中高剂量固定剂量组合中测量布地奈德和福莫特罗的实际剂量排放。
Eur J Pharm Sci. 2019 Nov 1;139:105059. doi: 10.1016/j.ejps.2019.105059. Epub 2019 Aug 28.
5
Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: the influence of flow and volume.干粉吸入器的空气动力学剂量排放特性,采用带有混合入口的安德森级联撞击器:流量和体积的影响。
Int J Pharm. 2013 Oct 15;455(1-2):213-8. doi: 10.1016/j.ijpharm.2013.07.036. Epub 2013 Jul 24.
6
Aerodynamic characteristics of a dry powder inhaler at low inhalation flows using a mixing inlet with an Andersen Cascade Impactor.在低吸气流量下使用混合入口和 Andersen 级联撞击器的干粉吸入器的空气动力学特性。
Eur J Pharm Sci. 2010 Mar 18;39(5):348-54. doi: 10.1016/j.ejps.2010.01.002. Epub 2010 Jan 20.
7
Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI).针对干粉吸入器(DPI),评估简化撞击器测量法(AIM)和高效数据分析(EDA)与全分辨率下一代撞击器(NGI)的对比情况。
AAPS PharmSciTech. 2017 Jul;18(5):1585-1594. doi: 10.1208/s12249-016-0625-9. Epub 2016 Sep 13.
8
The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions.干粉吸入气雾剂药物吸入前呼气对呼吸参数、喷出剂量和气溶胶粒径分布的影响。
Int J Pharm X. 2023 Feb 4;5:100167. doi: 10.1016/j.ijpx.2023.100167. eCollection 2023 Dec.
9
The dry powder inhaler features of the Easyhaler that benefit the management of patients.易纳器干粉吸入器的特点有利于患者的管理。
Expert Rev Respir Med. 2020 Apr;14(4):345-351. doi: 10.1080/17476348.2020.1721286. Epub 2020 Feb 4.
10
Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort Turbuhaler.使用中强度 Symbicort Turbuhaler 固定剂量组合(FDC)吸入时,使用 COPD 患者吸入特征进行真实生活剂量发射特性描述。
Int J Pharm. 2017 Apr 30;522(1-2):137-146. doi: 10.1016/j.ijpharm.2017.02.057. Epub 2017 Feb 28.

引用本文的文献

1
Inspiratory Profiles Through Easyhaler Dry Powder Inhaler During Acute Bronchoconstriction.急性支气管收缩期间通过易纳器干粉吸入器的吸气曲线
J Aerosol Med Pulm Drug Deliv. 2025 Apr;38(2):83-89. doi: 10.1089/jamp.2024.0045. Epub 2025 Feb 7.
2
Pharmaceutical, Clinical, and Regulatory Challenges of Reformulating Pressurized Metered-Dose Inhalers to Reduce Their Environmental Impact.重新设计压力定量吸入器以减少其环境影响所面临的制药、临床和监管挑战。
J Aerosol Med Pulm Drug Deliv. 2025 Feb;38(1):26-36. doi: 10.1089/jamp.2024.0023. Epub 2024 Nov 6.
3
Investigating the Accuracy of the Digihaler, a New Electronic Multidose Dry-Powder Inhaler, in Measuring Inhalation Parameters.
研究新型电子多剂量干粉吸入器 Digihaler 在测量吸入参数方面的准确性。
J Aerosol Med Pulm Drug Deliv. 2022 Jun;35(3):166-177. doi: 10.1089/jamp.2021.0031. Epub 2021 Dec 29.
4
Consistent Dosing Through the Salmeterol-Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: Robustness Analysis Across the Easyhaler Lifetime.通过沙美特罗氟替卡松丙酸酯易纳器进行稳定剂量给药治疗哮喘和慢性阻塞性肺疾病:易纳器整个生命周期的稳健性分析。
J Aerosol Med Pulm Drug Deliv. 2021 Jun;34(3):189-196. doi: 10.1089/jamp.2020.1592. Epub 2020 Sep 22.
5
The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers.两次单独吸入后吸气参数对低阻力和高阻力干粉吸入器中茶碱剂量释放的影响。
Saudi Pharm J. 2020 Jan;28(1):74-86. doi: 10.1016/j.jsps.2019.11.007. Epub 2019 Nov 13.
6
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.了解干粉吸入器:关键技术和患者偏好属性。
Adv Ther. 2019 Oct;36(10):2547-2557. doi: 10.1007/s12325-019-01066-6. Epub 2019 Sep 2.
7
Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice.布地奈德/富马酸福莫特罗单吸入剂联合治疗在支气管哮喘患者日常临床实践中的疗效评估。
Adv Ther. 2017 Dec;34(12):2648-2660. doi: 10.1007/s12325-017-0641-5. Epub 2017 Nov 8.